Advances in penumbra imaging with MR

Cerebrovascular Diseases

Volumn 17, Issue SUPPL. 3, 2004, Pages 23-27

  Davis, Stephen M ^a   Donnan, Geoffrey A ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Ischaemic stroke; Magnetic resonance imaging; Mismatch; Penumbra; Stroke outcome

Indexed keywords

DESMOTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ARTERY OCCLUSION; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; COOLING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL PARAMETERS; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PATIENT MONITORING; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; OXYGEN; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1642495953     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075301     Document Type: Conference Paper

References (28)

1. + at critical levels of brain ischemia. Stroke 1977;8:51-57.
2. Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981;12:723-725.
3. Donnan GA, Davis SM: Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol 2002;1:417-425.
4. 15O positron emission tomography. Stroke 1981;12:454-459.
5. 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol 2000;48:228-235.
6. Davis SM, Tress B, Barber PA, Darby D, Parsons M, Gerraty R, Yang Q, Li T, Donnan GA, Desmond P: Echoplanar magnetic resonance imaging in acute stroke. J Clin Neurosci 2000;7:3-8.
7. Baird AE, Warach S: Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583-609.
8. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad KO, Edelman RR, Warach S: Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41: 581-589.
9. Parsons MW, Yang Q, Barber AP, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM: Perfusion magnetic resonance imaging maps in hyperacute stroke. Relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke 2001;32:1581-1587.
10. Butcher K, Parson M, Baird T, Barber A, Donnan G, Desmond P, Tress B, Davis S: Perfusion thresholds in acute stroke thrombolysis. Stroke 2003;34:2159-2164.
11. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, GobinYP, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Woods RP, Alger JR: Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology 2001;57:2015-2021.
12. Minematsu K, Li L, Sotak CH, Davis MA, Fisher M: Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 1992;23:1304-1310.
13. Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM: Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999;30:2043-2052.
14. Marchal G, Beaudouin V, Rioux P, de la Sayette V, Le Doze F, Viader F, Derlon JM, Baron JC: Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: A correlative PET-CT study with voxel-based data analysis. Stroke 1996;27:599-606.
15. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM: Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418-426.
16. Barber PA, Parsons MW, Desmond PM, Donnan GA, Tress BM, Davis SM: Use of PWI and DWI measures in the design of 'Proof of Concept' trials. J Neuroimaging (in press).
17. Wardlaw JM, Sandercock PA, Berge E: Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke 2003;34:1437-1442.
18. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM: Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28-37.
19. Hacke W: Desmoteplase In Acute Ischemic Stroke (DIAS). 28th International Stroke Conference, Feb 2003, Phoenix. Abstract available at URL: http://www.strokeconference.org/sc-includes/pdfs/CTP14.pdf. Accessed 15 August 2003.
20. Anon: DEDAS. Dose escalation study of desmoteplase in acute ischemic stroke. Available at URL: http://www.strokecenter.org/trials/browse.asp?browse = A&condition = 4. Accessed 15 August 2003.
21. Bradford A, Lees K for the IMAGES Study Investigators and Co-ordinating Centre: Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial. Curr Control Trials Cardiovasc Med 2000;1:184-190.
22. Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo JM, Whitehead J: Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial. Lancet 2000;355:1949-1954.
23. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R: Effect of citicoline in ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol 2000;48:713-722.
24. Krieger DW, De Georgia MA, Devlin T, Jauss M, Rordorf G, Koroshetz WJ, Davis S: Cooling acute ischemic brain damage (COOL AID): A randomized pilot trial of endovascular cooling for patients with acute ischemic stroke. Stroke 2003;34:248.
25. Baird TA, Parsons M, Barber PA, Butcher KS, Desmond PM, Tress BM, Colman PG, Jerums G, Chambers BR, Davis SM: The Influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci 2002;9:618-626.
26. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM: Acute hyperglycemia adversely affects stroke outcome: An MR imaging and spectroscopy study. Ann Neurol 2002;52:20-28.
27. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-2214.
28. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS: Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999;30:793-799.